Literature DB >> 1443381

Concentration of refluxed acid and esophageal mucosal injury.

R M Bremner1, P F Crookes, T R DeMeester, J H Peters, H J Stein.   

Abstract

The hallmark of gastroesophageal reflux disease (GERD) is an increase in esophageal exposure to gastric juice. This exposure can result in complications such as esophagitis, stricture, and Barrett's esophagus. The aim of this study is to determine if there are specific pH exposure patterns that are associated with the development of these complications. The 24-hour esophageal pH data for 50 normal subjects and 154 patients with proven GERD were analyzed for time spent at different pH intervals. Increased esophageal acid exposure at a given interval occurred when the cumulative time of exposure exceeded the 95th percentile of that measured in the 50 normal subjects for that interval. The greatest prevalence of mucosal damage was found in the those patients with increased esophageal exposure to pH 0 to 2, corresponding to the known pKa of pepsin. This exposure was not related to a hypersecretory state. In addition, mucosal injury was associated with an increased esophageal exposure to pH 7 to 8. We conclude that mucosal injury in patients with GERD is related to the exposure time to gastric juice with a pH of less than 2 or greater than 7.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443381     DOI: 10.1016/s0002-9610(05)81193-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

Review 1.  [Correct diagnosis for indication in gastroesophageal reflux disease].

Authors:  A H Hölscher; E Bollschweiler; Ch Gutschow; P Malfertheiner
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

2.  Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?

Authors:  Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

3.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Gastroesophageal reflux in achalasia. When is reflux really reflux?

Authors:  P F Crookes; S Corkill; T R DeMeester
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

5.  Is pH Testing Necessary Before Antireflux Surgery in Patients with Endoscopic Erosive Esophagitis?

Authors:  Katrin Schwameis; Brenda Lin; Jordan Roman; Ketetha Olengue; Steve Siegal; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2017-08-25       Impact factor: 3.452

6.  Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized.

Authors:  W K Kauer; J H Peters; T R DeMeester; A P Ireland; C G Bremner; J A Hagen
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

7.  Acid reflux is a poor predictor for severity of erosive reflux esophagitis.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Stephen J Sontag
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

8.  Prolapse gastropathy syndrome may be a predictor of pathologic acid reflux.

Authors:  Jin-Soo Kim; Hyung-Keun Kim; Young-Seok Cho; Hiun-Suk Chae; Byung-Wook Kim; Jin-Il Kim; Sok-Won Han; Kyu-Yong Choi
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

9.  pH-metric analysis after successful antireflux surgery: comparison of 24-hour pH profiles in patients undergoing floppy fundoplication or Roux-en-Y duodenal diversion.

Authors:  J T Salminen; J A Salo; J A Tuominen; O J Rämö; M Färkkilä; S P Mattila
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

Review 10.  Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux.

Authors:  Alexios S Vardouniotis; Alexander D Karatzanis; Eleni Tzortzaki; Elias Athanasakis; Katerina D Samara; Georgios Chalkiadakis; Nikolaos Siafakas; George A Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.